RFG
VRTX icon

RFP Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

RFP Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-158
Closed -$74.1K – 780
2024
Q2 		$74.1K Buy
158
+23
+17% +$9.98K 0.03% 187
2024
Q1 		$56.4K Hold
135
– – 0.02% 194
2023
Q4 		$54.9K Hold
135
– – 0.02% 191
2023
Q3 		$46.9K Hold
135
– – 0.02% 203
2023
Q2 		$47.5K Hold
135
– – 0.02% 218
2023
Q1 		$42.5K Hold
135
– – 0.05% 123
2022
Q4 		$39K Buy
+135
New +$41.1K 0.02% 214

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

RFP Financial Group's VRTX Position: Q3 2024 in Review

RFP Financial Group sold out of Vertex Pharmaceuticals (VRTX) in Q3 2024, closing a stake of 158 shares — an estimated $74.1K sold.

RFP Financial Group first reported a position in VRTX in Q4 2022 and held it in 7 quarters. The position peaked at $74.1K in Q2 2024. 1,548 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

  • RFP Financial Group reported no remaining Vertex Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 158 Vertex Pharmaceuticals shares in Q3 2024, an estimated $74.1K.
  • RFP Financial Group first reported a position in Vertex Pharmaceuticals in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's Vertex Pharmaceuticals position peaked at $74.1K in Q2 2024.
  • 1,548 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.